PepVault
/ database / Metabolic

AOD-9604

Also: Anti-Obesity Drug 9604 · GH fragment 176-191

GH-fragment with lipolytic action and no growth signaling.

Evidence
emerging
Legal status
research only
Half-life
Short
Routes
subq
View on Limitless LifeAdd to compare
What it is

AOD-9604 was originally developed as an obesity drug. It produces fat-loss-like effects of GH without engaging the IGF-1 axis. Clinical results in humans have been mixed.

Mechanism

Modified C-terminal fragment of GH. Promotes lipolysis without affecting IGF-1.

Outcomes it's matched to
Safety

Well tolerated in trials; efficacy modest.

  • Pregnancy
Legal context

Research-only; approved as food supplement in some jurisdictions.

1:1 GUIDANCE

Have questions about this peptide?

Get free 1:1 guidance from a peptide professional before you start. They'll help you think through dosing, stacking, and whether this fits your goals.

REQUEST A CALL →
PepVault

An outcome-driven reference for modern peptides. Educational only — not medical advice, not a sales platform, not affiliated with any clinic.

Disclaimer: PepVault is an educational resource. Nothing on this site is medical advice. Many peptides discussed are research compounds and are not approved by the FDA or equivalent agencies. Always consult a qualified clinician before starting any protocol.

© 2026 PepVault